Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced hyperkalemia.

S P Ponce, A E Jennings, N E Madias

    Medicine
    |November 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Drug-induced hyperkalemia remains a significant risk, with hospital incidence at 1-10%. New medications and ignored risk factors like diabetes and kidney issues contribute to this persistent danger.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Report of Two Deaths from Partial Chloroform-Anæsthesia, with Remarks.

    Daniel's Texas medical journal·2023
    Same author

    A decade of system- and population-based osteoporosis care improvement.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2011
    Same author

    Redesigning the care of rheumatic diseases at the practice and system levels. Part 1: practice level process improvement (Redesign 101).

    Clinical and experimental rheumatology·2007
    Same author

    Redesigning the care of rheumatic diseases at the practice and system levels. Part 2: system level process improvement (Redesign 201).

    Clinical and experimental rheumatology·2007
    Same author

    Quantitative measurement of patient status in the regular care of patients with rheumatic diseases over 25 years as a continuous quality improvement activity, rather than traditional research.

    Clinical and experimental rheumatology·2007
    Same author

    CREB transcription factor modulates Bcl2 transcription in response to C5a in HL-60-derived neutrophils.

    European journal of clinical investigation·2006
    Same journal

    A meta-analysis of the effects of Baduanjin training on the human body temperature based on infrared thermography technology.

    Medicine·2026
    Same journal

    The predictive ability of "TyG_CVAI" for incident stroke in individuals with different glycemic metabolic status: A national cohort study.

    Medicine·2026
    Same journal

    Symptoms and quality of life in gynecological cancer patients after surgery: Application of latent profile and network analysis.

    Medicine·2026
    Same journal

    Massive hemoptysis as the initial presentation of Behçet disease complicated by multisite thromboembolism: A case report.

    Medicine·2026
    Same journal

    Dextromethorphan-bupropion-associated pharmacovigilance signals based on the FAERS database: An observational study.

    Medicine·2026
    Same journal

    Effects of Mulligan sustained natural apophyseal glide mobilizations on pain, mobility, and lumbar-related disability in chronic non-specific low back pain: A systematic review and meta-analysis.

    Medicine·2026
    See all related articles

    Area of Science:

    • Clinical Pharmacology
    • Nephrology
    • Internal Medicine

    Background:

    • Drug-induced hyperkalemia presents a persistent and significant clinical challenge.
    • The risks associated with potassium chloride, first documented over a decade ago, have not diminished.
    • Current hospital incidence of hyperkalemia ranges from 1-2% to as high as 10%.

    Purpose of the Study:

    • To review current data on drug-induced hyperkalemia.
    • To identify ongoing risks and contributing factors.
    • To emphasize the need for improved prevention strategies.

    Main Methods:

    • Comprehensive review of existing literature and data on drug-induced hyperkalemia.
    • Analysis of risk factors, including medications and patient comorbidities.

    Related Experiment Videos

  • Evaluation of the incidence and trends of hyperkalemia in hospital settings.

    • Main Results:

    • The risk of hyperkalemia in hospitals remains substantial, with incidence rates between 1-10%.
    • Potassium chloride supplements and potassium-sparing diuretics are primary causes, joined by newer agents like ACE inhibitors and NSAIDs.
    • Key risk factors such as diabetes mellitus, renal insufficiency, hypoaldosteronism, and advanced age are frequently overlooked.

    Conclusions:

    • The situation regarding drug-induced hyperkalemia has not improved, highlighting a critical gap in patient safety.
    • Indiscriminate use of potassium supplements and potassium-sparing diuretics must be curtailed.
    • Effective prevention requires greater awareness and management of known risk factors in clinical practice.